SUMMIT NUCLEAR VISION NEUROSPECT
K-Number: K920958 · 1992-08-07
Advertisement
Device Summary
Frequently Asked Questions
What is the SUMMIT NUCLEAR VISION NEUROSPECT?
SUMMIT NUCLEAR VISION NEUROSPECT is a medical device that received FDA 510(k) clearance on 1992-08-07. The listed applicant is Summit Nuclear. The 510(k) number is K920958.
When did SUMMIT NUCLEAR VISION NEUROSPECT receive FDA 510(k) clearance?
SUMMIT NUCLEAR VISION NEUROSPECT received FDA 510(k) clearance on 1992-08-07, under 510(k) number K920958.
Who is the listed applicant for SUMMIT NUCLEAR VISION NEUROSPECT?
The FDA 510(k) record lists Summit Nuclear as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for SUMMIT NUCLEAR VISION NEUROSPECT?
The FDA product code for SUMMIT NUCLEAR VISION NEUROSPECT is KPS.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Summit Nuclear as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: KPS)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement